The role of some miRNAs in bladder cancer chemoresistance to cisplatin | ||
| Mansoura Journal of Biology | ||
| Volume 53, Issue 4, December 2021, Pages 37-41 PDF (688.27 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/mjb.2021.460005 | ||
| Authors | ||
| Sameha A. Omar* 1; Sameh Shabana1; Amira Awadalla2; Azza I. Othman3 | ||
| 1Zoology Department, Faculty of Science, Mansoura University, Egypt | ||
| 2Urology and Nephrology center, Mansoura University, Egypt. | ||
| 3Zoology Department, Faculty of Science, Mansoura University, Egypt. | ||
| Abstract | ||
| For many years, the standard treatment for metastatic bladder cancer was cisplatin. The main cause of treatment failure is the resistance to cisplatin. Resistance to cisplatin remains the main obstacle to prevent clinical treatment and cause of patients’ poor prognosis. In this study, we aimed to evaluate the role of microRNAs (miRNAs) and their effect on genes that can be targeted by the three miRNAs and their role in chemoresistance to differentiate between responding and non responding patients. Samples were collected from muscle invasive bladder cancer (MIBC) patients who received 4 cycles of cisplatin after cystectomy, the expression of miR-21, miR-143, miR-155, and their target genes (VEGF-C, AKT, and DMTF-1) were assessed in tumor bladder tissue sample. The results of this study suggested miR-21up regulation, decrease miR-143 and increase miR-155 expression and their target genes; increase VEGF-C, up regulation of AKT and down regulation DMTF-1; may play a vital role in chemoresistance and can be a cause of disease recurrence | ||
| Keywords | ||
| chemoresistance; miRNAs; MIBCs | ||
|
Statistics Article View: 3 PDF Download: 1 |
||
